Samsung Biologics Wins Manufacturing Approval from Europe
SEOUL, Dec. 13 (Korea Bizwire) — South Korean biopharmaceutical firm Samsung Biologics Co. said Wednesday it has won approval from European health authorities to manufacture drugs at its plant in Europe. The European Medicines Agency (EMA) accepted Samsung Biologics’ manufacturing application to make 152,000 liters of biosimilars at the plant, officials said. The approval comes [...]